Amjad Qasim Manzoor, Danishwar Mahmood, Pervaiz Salman, Kumar Satesh, Varrassi Giustino
Internal Medicine, Allama Iqbal Medical College, Lahore, PAK.
Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA.
Cureus. 2023 May 28;15(5):e39614. doi: 10.7759/cureus.39614. eCollection 2023 May.
Olfactory neuroblastoma is a rare, undifferentiated carcinoma of the nasal cavity. It is an extremely rare malignancy, usually occurring in the sixth decade of life with no known underlying cause. In this case report, we present a 71-year-old male with an enlarging facial mass near the right medial nasal bridge, initially diagnosed as undifferentiated carcinoma on biopsy and later confirmed as olfactory neuroblastoma eroding into the anterior skull base. Our patient presented with the signs and symptoms of epiphora, epistaxis, intermittent headaches, anosmia, and an enlarging facial mass. The treatment modalities include surgery, radiation therapy, and chemotherapy. The purpose of this case report is to highlight the importance of chemotherapy and adjuvant radiotherapy for treatment without the need for surgery. Further studies need to be done to divulge the risk factors for olfactory neuroblastoma and to implore new chemotherapeutic treatment modalities that minimize long-term mortality and morbidity.
嗅神经母细胞瘤是一种罕见的鼻腔未分化癌。它是一种极其罕见的恶性肿瘤,通常发生在60岁左右,病因不明。在本病例报告中,我们介绍了一名71岁男性,其右鼻内侧桥附近面部肿物逐渐增大,活检最初诊断为未分化癌,后来确诊为侵蚀前颅底的嗅神经母细胞瘤。我们的患者表现出流泪、鼻出血、间歇性头痛、嗅觉丧失和面部肿物增大等症状和体征。治疗方式包括手术、放射治疗和化疗。本病例报告的目的是强调化疗和辅助放疗在无需手术治疗中的重要性。需要进一步研究以揭示嗅神经母细胞瘤的危险因素,并探索新的化疗治疗方式,以尽量降低长期死亡率和发病率。